Read + Share
Fleischmann R. Biologic disease-modifying anti-rheumatic drugs and kinase inhibitors:
differences in efficacy and safety in rheumatoid arthritis. Clin Rheumatol 2021 Sep 24. pii: 10.1007/s10067-021-05933.
PMID: 34561810
|
 |
|
Fleischmann R. Biologic disease-modifying anti-rheumatic drugs and kinase inhibitors:
differences in efficacy and safety in rheumatoid arthritis. Clin Rheumatol 2021 Sep 24. pii: 10.1007/s10067-021-05933.
PMID: 34561810
|
|
|
|